COMMUNIQUÉS West-GlobeNewswire

Canada House Wellness Group Inc. Accelerates Phenotyping of 62 In-House Genetics
14/02/2019
TORONTO, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) and Abba Medix Corp. (“Abba”), CHV’s wholly owned Licensed Producer has accelerated their [...]
Axovant Announces Formation of Arvelle Therapeutics and Strategic Transition of Legacy Small Molecule Team Into Newly Formed Company
14/02/2019
Transition of small molecule expertise to Arvelle completes transformation of Axovant into a company focused exclusively on gene therapies Axovant will receive a preferred equity stake in Arvelle, which has received [...]
Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria
14/02/2019
REDWOOD CITY, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that Nestlé Health Science has exercised its option to obtain an exclusive license [...]
Amarin to Present at the 8th Annual SVB Leerink Global Healthcare Conference
14/02/2019
BEDMINSTER, N.J., and DUBLIN, Ireland, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Terveystalo Plc: Notice of the Annual General Meeting
14/02/2019
Terveystalo Plc Stock Exchange Release 14 February 2019 at 9:05 EET Notice is given to the shareholders of Terveystalo Plc of the Annual General Meeting to be held on Thursday, 4 April 2019 at 3:00 p.m. at Marina [...]
Terveystalo Plc: Terveystalo Group Financial Statements Bulletin 2018
14/02/2019
Terveystalo Plc Stock Exchange Release 14 February 2019 at 9:00 EET Record year, strong platform for growth October-December 2018 in brief Revenue increased by 4.2 percent year-on-year to EUR 197.9 million (189.9) [...]
Ossur Hf : Annual General Meeting 7 March 2019
14/02/2019
Announcement no. 10/2019 14 February 2019 Össur hf. - Annual General Meeting 7 March 2019 Össur hf.'s Annual General Meeting will be held on Thursday 7 March 2019 at 9:00 am (GMT) at the Company's offices at Grjótháls 5 [...]
Motif Bio Receives Complete Response Letter from the FDA
14/02/2019
NEW YORK, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the Company has received a [...]
Addex and Indivior to Accelerate Additional GABAB PAM Compounds for Addiction as Indivior Elects to Stop Development of ADX71441
14/02/2019
Geneva, Switzerland, 14 th February 2019 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, and Indivior PLC (LON: INDV) announced today that they [...]
MDxHealth (R): MDxHealth Signs Partnership with LifeLabs to Make SelectMDx available in Canada
14/02/2019
NEWS RELEASE IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CET, February 14, 2019 - MDxHealth SA (Euronext: MDXH.BR) today announces that it has signed an exclusive distribution agreement with LifeLabs to make SelectMDx ® , [...]
MDxHealth (R) : MDxHealth conclut un partenariat avec LifeLabs pour commercialiser SelectMDx au Canada
14/02/2019
COMMUNIQUÉ DE PRESSE IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 CET, 14 février 2019 - MDxHealth SA (Euronext : MDXH.BR) annonce aujourd'hui qu'elle a signé un accord de distribution exclusive avec LifeLabs pour [...]
Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common Stock
14/02/2019
CHICAGO, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]
Caladrius Biosciences Reports Top-Line Data for the Phase 2a Sanford Project: T-Rex Trial of CLBS03 for Recent Onset Type 1 Diabetes
13/02/2019
BASKING RIDGE, N.J., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company with multiple development [...]
Mesoblast Financial Results Webcast for Half Year, Q2 Ended December 31, 2018
13/02/2019
NEW YORK and MELBOURNE, Australia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) will report financial results for the half year and second quarter ended December 31, 2018 in a webcast [...]
National Research Corporation Declares Quarterly Dividend
13/02/2019
Lincoln, Nebraska, Feb. 13, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 (nineteen cents) per share [...]
BeiGene to Hold Fourth Quarter and Full Year 2018 Financial Results Conference Call on February 27, 2019 and Host Investor Event in Hong Kong
13/02/2019
CAMBRIDGE, Mass., and BEIJING, China, Feb. 13, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Novartis receives FDA approval for Egaten® for the treatment of fascioliasis, a neglected tropical disease
13/02/2019
Egaten is the only drug approved in the US for the treatment of people with fascioliasis and is currently the only treatment recommended by the WHO Fascioliasis, commonly known as liver fluke infestation, is estimated [...]
EyePoint Pharmaceuticals Secures Up to $60 Million Debt Facility
13/02/2019
– Provides support for the product launches of YUTIQ™ and DEXYCU™ – WATERTOWN, Mass., Feb. 13, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to [...]
Adverum to Present at the 8th Annual SVB Leerink Global Healthcare Conference
13/02/2019
MENLO PARK, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the [...]

Pages